4//SEC Filing
Lang James Paul 4
Accession 0001628280-23-000210
CIK 0001448431other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:04 PM ET
Size
6.7 KB
Accession
0001628280-23-000210
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Lang James Paul
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-12-30−409→ 0 total→ Common Stock (409 underlying) - Exercise/Conversion
Common Stock
2022-12-30+409→ 39,403 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On December 30, 2021 the reporting person was granted 409 restricted stock units which vested in full on December 30, 2022.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001703090
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:04 PM ET
- Size
- 6.7 KB